World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
42
Citations
9393
World Ranking
5322
National Ranking
2021

Best Publications

  • SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.

    Petra Mlcochova;Steven A Kemp;Steven A Kemp;Mahesh Shanker Dhar;Guido Papa

  • Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

    Unknown

  • Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation

    Akatsuki Saito;Takashi Irie;Rigel Suzuki;Tadashi Maemura;Tadashi Maemura

  • Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike

    Unknown

  • Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants

    Unknown

  • Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5

    Unknown

  • Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant

    Unknown

  • Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis

    Bruce C. Trapnell;Chin-Shyan Chu;Paavo K. Paakko;Tyrone C. Banks

  • A potent human immunodeficiency virus type 1 protease inhibitor, UIC-94003 (TMC-126), and selection of a novel (A28S) mutation in the protease active site.

    Kazuhisa Yoshimura;Ryohei Kato;Mark F. Kavlick;Aline Nguyen

  • Amino acid substitutions in Gag protein at non-cleavage sites are indispensable for the development of a high multitude of HIV-1 resistance against protease inhibitors

    Hiroyuki Gatanaga;Yasuhiro Suzuki;Hsinyi Tsang;Kazuhisa Yoshimura;Kazuhisa Yoshimura

  • Novel Low Molecular Weight Spirodiketopiperazine Derivatives Potently Inhibit R5 HIV-1 Infection through Their Antagonistic Effects on CCR5

    Kenji Maeda;Kazuhisa Yoshimura;Shiro Shibayama;Hiromu Habashita

  • Virological characteristics of SARS-CoV-2 BA.2 variant

    Unknown

  • JE-2147: A dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1

    Kazuhisa Yoshimura;Ryohei Kato;Keisuke Yusa;Mark F. Kavlick

  • Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant

    Unknown

  • Current status of HIV/AIDS in the ART era.

    Unknown

  • Recurrent HIV‐1 Integration at the<i>BACH2</i>Locus in Resting CD4<sup>+</sup>T Cell Populations during Effective Highly Active Antiretroviral Therapy

    Unknown

  • Syntheses of 4‘-C-Ethynyl-β-d-arabino- and 4‘-C-Ethynyl-2‘-deoxy-β-d-ribo-pentofuranosylpyrimidines and -purines and Evaluation of Their Anti-HIV Activity

    Hiroshi Ohrui;Satoru Kohgo;Kenji Kitano;Shinji Sakata

  • Enhanced Exposure of Human Immunodeficiency Virus Type 1 Primary Isolate Neutralization Epitopes through Binding of CD4 Mimetic Compounds

    Kazuhisa Yoshimura;Shigeyoshi Harada;Junji Shibata;Makiko Hatada

  • Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: Pharmacokinetic drug interactions and antiviral activity

    J Falloon;S Piscitelli;S Vogel;B Sadler

  • SOCS1 is an inducible host factor during HIV-1 infection and regulates the intracellular trafficking and stability of HIV-1 Gag

    Akihide Ryo;Naomi Tsurutani;Kenji Ohba;Ryuichiro Kimura

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Recently Published Articles